🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will determine if bone marrow stromal cells can be used as a gra...
Status
Terminated
Location
Suburban Hospital
Start Date
2007-01-29
Trial ID
NCT00435877
The study aims at: 1. Perform a multilayer analysis relying on tight integ...
Status
Recruiting
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Start Date
2024-02-29
Trial ID
NCT05941234
Treatments Being Tested
Pharmacogenetics is an area of Pharmacology that studies the contribution o...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT02450487
Treatments Being Tested
Microbiota contributes to the immunological, hormonal and metabolic homeost...
Status
Unknown
Location
Koc University Hospital
Start Date
2020-04-01
Trial ID
NCT04165252
Treatments Being Tested
This case-control study will be conducted between January and June 2026 and...
Status
Enrolling By Invitation
Location
University of babylon
Start Date
2026-01-31
Trial ID
NCT07579338
This prospective cohort study is part of the Clinnova programme and aims to...
Status
Recruiting
Location
Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)
Start Date
2024-12-10
Trial ID
NCT06526364
Treatments Being Tested
A total of 22 subjects will be included in the study. The subjects who were...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12
Trial ID
NCT06557447
The purpose of this study is to examine the agreement between venous blood ...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00569634
Treatments Being Tested
Uroflowmetry is the one of the most commonly used non-invasive test for eva...
Status
Completed
Location
Marmara University School of Medicine, Urology Department
Start Date
2024-10-01
Trial ID
NCT06814847
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093